EUVIMEDEUVIMED entdecken
Crossref

Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma

Anning Zuo, Jinyu Li, Siyuan Weng, Hui Xu, Yuyuan Zhang, Libo Wang, Zhe Xing, Peng Luo, Quan Cheng, Jing Li, Xinwei Han iD, Zaoqu Liu

Journal of Proteome Research · 2024

DOI: 10.1021/acs.jproteome.4c00036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Anning Zuo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Epigenesis, Genetic, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsEpigenesis, GeneticEpithelial-Mesenchymal TransitionMatrix Metalloproteinase 12Gene Expression Regulation, NeoplasticDisease ProgressionHumansPrognosisMicroRNAsCell ProliferationCell Line, TumorNeoplastic Stem CellsDNA Methylation

Stichwörter der Autor:innen

epigeneticshepatocellular carcinomaheterogeneitymolecular subtyping

Substanzen

Matrix Metalloproteinase 12MicroRNAsMMP12 protein, human

Autor:innen und Institutionen

  • Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
  • Center of Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
  • Department of Neurosurgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, China.

ORCID-Profile: Xinwei Han

Zitieren

APA

Zuo, A., Li, J., Weng, S., Xu, H., Zhang, Y., Wang, L., Xing, Z., Luo, P., Cheng, Q., Li, J., Han, X., & Liu, Z. (2024). Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00036

Vancouver

Zuo A, Li J, Weng S, Xu H, Zhang Y, Wang L, et al. Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.4c00036

BibTeX
@article{Zuo2024,
  author = {Zuo, Anning and Li, Jinyu and Weng, Siyuan and Xu, Hui and Zhang, Yuyuan and Wang, Libo and Xing, Zhe and Luo, Peng and Cheng, Quan and Li, Jing and Han, Xinwei and Liu, Zaoqu},
  title = {Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma},
  journal = {Journal of Proteome Research},
  year = {2024},
  doi = {10.1021/acs.jproteome.4c00036}
}
Kostenlos starten →